Harrow has launched what it’s calling a “first of its kind” prescribing and access pharmacy platform—by a U.S. pharmaceutical company—for eyecare professionals(ECPs), dubbed HarrowRx.
This platform is just the latest offering the company has rolled out to support easier patient and ECP access to its product portfolio
The latest, you say?
Indeed. In fact, earlier this year Harrow unveiled a direct-to-prescriber cash-pay program intended to improve nationwide access to its FDA-approved ophthalmic products.
- Read up on that PharmaPack program.
And over the last 2 years: The company has launched a number of product accessibility programs:
- See here for our rundown on the VEVYE Access for All initiative.
- Check out the Harrow Cares program (in partnership with Cencora).
- Click here for details on its partnership with GoodRx for discounted products.
That’s quite the lineup … now to this new platform.
Officially: HarrowRx is a licensed pharmacy registered on the Surescripts network (meaning it appears in the pharmacy finder of connected EMRs).
In more basic terms: HarrowRx is designed as a prescribing and access pharmacy platform enabling ECPs to access its entire product portfolio within their existing electronic medical record (EMR) systems.
All existing EMR systems?
According to Harrrow—yes.
Wow. So how does it work?
The platform routes each prescription to its appropriate fulfillment channel to offer eligible patients a more straightforward process and pathway to receiving their medicine.
Per Harrow CEO Mark. L. Baum: HarrowRx is designed to ease the frustrations facing today’s prescribers: from determining which specialty pharmacy or hub handles each product to remembering to complete prior authorization forms—and ensuring patients have access to every available manufacturing program.
- “We created HarrowRx to take that complexity off their plates and build upon the trust that our customers have in the Harrow brand,” he stated.
Is Harrow’s pharmacy partner involved in this?
Indeed. As with prior initiatives, PhilRx is at the center of the “behind the scenes” operations that go into fulfilling medications.
The process:
- Harrow’s “buy-and-bill” products are routed through their respective distributors for support and fulfillment.
- Practices, meanwhile, use just “one entry point” as each medication follows its respective fulfillment pathway to patients.
Talk about the affordability factor.
Per the company, HarrowRx connects applicable prescriptions with any available benefits verification, savings, and patient-supported programs to help patients not only navigate coverage but also reduce the risk for unnecessary out-of-pocket costs.
- Among these: completion of insurance authorization forms
Circle back to the products available through this platform …
As CEO Mark L. Baum noted, HarrowRx is intended for use with the company’s “entire branded portfolio.”
To refresh: Harrow’s U.S. commercial portfolio includes 15 branded, FDA-approved prescription drugs:
- VEVYE (cyclosporine 0.1%)
- TYRVAYA (varenicline nasal spray)
- IHEEZO (chloroprocaine 3% gel)
- TRIESENCE (triamcinolone injectable)
- IOPIDINE (apraclonidine 1%)
- VERKAZIA (cyclosporine emulsion 0.1%)
- ZERVIATE (cetirizine 0.24%)
- NATACYN (natamycin 5%)
- VIGAMOX (moxifloxacin 0.5%)
- FLAREX (fluorometholone acetate 0.1%)
- MAXIDEX (dexamethasone 0.1%)
- MAXITROL (neomycin/polymyxin B/dexamethasone)
- TOBRADEX ST (tobramycin/dexamethasone)
- ILEVRO (nepafenac 0.3%)
- NEVANAC (nepafenac 0.1%)
That’s quite the list. So how can ECPs get started with this program?
Prescribers can search for HarrowRx by name or via its NCPDP ID (3694886) or NPI (1578473732) in the pharmacy finder of a connected EMR.
- To note: Either option can be selected without installing separate prescribing software or creating another login.
Once identified and chosen, they’re free to send the prescription as usual—though fulfillment options and patient-supported programs may vary by product and eligibility.
And on the off chance HarrowRx doesn’t appear in their EMR’s pharmacy finder?
If that’s the case, prescribers can also send prescriptions to the pharmacy platform via two alternative methods:
- Phone (855-977-0975)
- Fax (855-977-0975)
For any other questions or additional support needed, the company advises contacting support (855-977-0975) or their Harrow account representative.